COMP <GO>
MTZ vs TMO // RETURN ON INVESTED CAPITAL (ROIC)
MasTec Inc. (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: MTZ 4
— TMO 9
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: TMO
LAST: $186.06 (+4.63%) • MKT CAP: $14.28B
roic
6.80%
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
roic
9.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MTZ VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MTZ | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 41.00% | 0.00 | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 6.80% | 9.30% | -2.50 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 16.1x | 30.4x | -14.30 | MTZ | /valuation <GO> |
| Free Cash Flow Yield | -0.68% | 2.40% | -3.08 | TMO | /fcf-yield <GO> |
| Operating Margin | 3.40% | 17.40% | -14.00 | TMO | /operating-margins <GO> |
| Net Profit Margin | 2.80% | 15.10% | -12.30 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 16.20% | 3.90% | +12.30 | MTZ | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.41 | 4.50 | -1.09 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.50% | 6.70% | -0.20 | MTZ | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 40.6 | 59.1 | -18.52 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.87 | 0.94 | -0.07 | TMO | /macro-sensitivity <GO> |
| Forward P/E Multiple | 30.1x | 36.3x | -6.20 | MTZ | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $14.28B | $262.22B | -$247.94B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MTZ REV | TMO REV | MTZ GROSS % | TMO GROSS % | MTZ FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $14.30B | $44.56B | 44.0% | 44.0% | -$97.7M | $6.29B |
| FY 2024 | $12.30B | $42.88B | 44.0% | 44.0% | $568.0M | $7.27B |
| FY 2023 | $12.00B | $42.86B | 44.0% | 44.0% | $147.5M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MTZ // BETA 0.87
TMO // BETA 0.94